News & Perspective

Jul 15, 2008

Jul 15, 2008

Indonesia details reasons for withholding H5N1 viruses

(CIDRAP News) – In a recent medical journal article, Indonesian officials detailed the rationale for their refusal to share H5N1 influenza virus samples with the World Health Organization (WHO), asserting that it was in part a response to violations of the WHO's own guidelines by scientists and laboratories.

Jul 17, 2008

Jul 17, 2008

Reports examine high H5N1 death rate in Indonesia

(CIDRAP News) – Recent reports from Indonesian health officials tie the high fatality rate in human H5N1 influenza cases there to the difficulty of diagnosing the disease, late treatment with antiviral drugs, and a shortage of well-equipped hospitals.

Oct 29, 2008

Oct 29, 2008

Experts stress vigilance over emerging, unpredictable diseases

See related article posted today: "US urged to launch major campaign against emerging diseases"

– WASHINGTON, DC (CIDRAP News) – Health authorities must remain alert to new and renascent disease threats, experts warned this week at an international medical meeting.

Feb 10, 2009

Feb 10, 2009

Panasonic's pandemic-related move fuels questions, concern

(CIDRAP News) – News reports that Panasonic Corp. has asked some of its overseas employees to send their families home to Japan because of the threat of pandemic influenza fueled puzzlement and speculation today about the global H5N1 risk and whether other companies might follow suit.

Feb 12, 2009

Feb 12, 2009

Panasonic addresses speculation over employee pandemic order

(CIDRAP News) – A spokesman for Panasonic Corp. said today that the company had no proprietary information about any increased risk of an influenza pandemic in December 2008 when it instructed some of its overseas employees to send their families back to Japan by September.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»